Journal: Lily Flower Journal of Biochemistry & Mental Health (LFJ-BMH)
Volume: 1 Issue: 1 Year: 2026
Article Type: Review
DOI: (Assigned after testing)
Authors:
Anastasiia Bezrodna, PhD
Mykola Shcherban, DMS
James Rubenstein, MD, PhD
Robert Marlin, MD
Victor H. Mudenda, PhD
Volume: 1 Issue: 1 Year: 2026
Article Type: Review
DOI: (Assigned after testing)
Authors:
Anastasiia Bezrodna, PhD
Mykola Shcherban, DMS
James Rubenstein, MD, PhD
Robert Marlin, MD
Victor H. Mudenda, PhD
Your browser does not support viewing this document. Click here to download the document.
Published Online: December 2025
Journal: Lily Flower Journal of Biochemistry & Mental Health (LFJ-BMH)
Volume: 1, Issue: 1, Year: 2026
Article Type: Review
DOI: Assigned upon registration
Journal: Lily Flower Journal of Biochemistry & Mental Health (LFJ-BMH)
Volume: 1, Issue: 1, Year: 2026
Article Type: Review
DOI: Assigned upon registration
How to Cite This Article
APA Style
Bezrodna, A., Shcherban, M., Rubenstein, J., Marlin, R., & Mudenda, V. H. (2025).
Prognostic factors and treatment outcomes in primary CNS lymphoma (PCNSL).
Lily Flower Journal of Biochemistry & Mental Health, 1(1).
https://lilyflowerofthevalley.org
Vancouver Style
Bezrodna A, Shcherban M, Rubenstein J, Marlin R, Mudenda VH.
Prognostic factors and treatment outcomes in primary CNS lymphoma (PCNSL).
Lily Flower Journal of Biochemistry & Mental Health. 2025;1(1).
APA Style
Bezrodna, A., Shcherban, M., Rubenstein, J., Marlin, R., & Mudenda, V. H. (2025).
Prognostic factors and treatment outcomes in primary CNS lymphoma (PCNSL).
Lily Flower Journal of Biochemistry & Mental Health, 1(1).
https://lilyflowerofthevalley.org
Vancouver Style
Bezrodna A, Shcherban M, Rubenstein J, Marlin R, Mudenda VH.
Prognostic factors and treatment outcomes in primary CNS lymphoma (PCNSL).
Lily Flower Journal of Biochemistry & Mental Health. 2025;1(1).
Keywords
Primary CNS Lymphoma; Prognostic Factors; Chemotherapy; Survival Outcomes; Oncology; Brain Tumors
Primary CNS Lymphoma; Prognostic Factors; Chemotherapy; Survival Outcomes; Oncology; Brain Tumors
Article History
Received: November 2025
Revised: December 2025
Accepted: December 2025
Published Online: December 2025
Received: November 2025
Revised: December 2025
Accepted: December 2025
Published Online: December 2025
Author Affiliations
Anastasiia Bezrodna, PhD
University of Medicine and Social Sciences (UMSS), Ukraine
Mykola Shcherban, DMS
Kharkiv National Medical University (KNMU), Ukraine
James Rubenstein, MD, PhD
University of California San Francisco, USA
Robert Marlin, MD
University of California San Francisco, USA
Victor H. Mudenda, PhD
Lily Flower of the Valley Corporation, Oakland, California, USA
University of Medicine and Social Sciences (UMSS), Ukraine (MD Candidate)
Anastasiia Bezrodna, PhD
University of Medicine and Social Sciences (UMSS), Ukraine
Mykola Shcherban, DMS
Kharkiv National Medical University (KNMU), Ukraine
James Rubenstein, MD, PhD
University of California San Francisco, USA
Robert Marlin, MD
University of California San Francisco, USA
Victor H. Mudenda, PhD
Lily Flower of the Valley Corporation, Oakland, California, USA
University of Medicine and Social Sciences (UMSS), Ukraine (MD Candidate)